Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EutropinPen Ease of Use and Safety Study
NCT03015909Phase 4Completed
- Sponsor
- LG Chem
- Start
- Aug 2016
- Primary completion
- Dec 2017
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of Eutropin in Idiopathic Short Stature (ISS), Small for gestational age (SGA), growth hormone deficiency (GHD), chronic kidney disease (CKD), Turner syndrome (TS), sponsored by LG Chem. Started Aug 2016; status: completed.
02
Drugs
Eutropin
03
Conditions
Idiopathic Short Stature (ISS)Small for gestational age (SGA)growth hormone deficiency (GHD)chronic kidney disease (CKD)Turner syndrome (TS)
Beyond the preview
Go deeper on NCT03015909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03015909.